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especially in patients at high risk for dislocation. The aim of this investigation was to analyze the
frequency and indications of the DMCS use in our praxis and to evaluate dislocation and cup revision
rates after a minimum follow-up of 2 years. MATERIALS AND METHODS: All patients implanted
with a DMCS from May 2008 to August 2011 were identified from our institutional database of primary
and revision THA procedures. Patient demographics, including ASA score, were recorded, along with
details of the surgical procedures, indications for DMCS use, and post-operative clinical course and any
complications. Radiographs were analyzed for implant positioning and radiological signs of loosening.
RESULTS: 1046 primary THA were implanted, of these 39 (4 %) primary DMCS. Indications were severe
neuromuscular disease (SND) (14), hip abductor degeneration (HAD) (9), cognitive dysfunction (CD)
(8) and others. 345 revision THA were performed, of these 50 (14 %) revision DMCS. Indications were
recurrent dislocations (27), multiple prior hip surgeries (13), HAD (5), CD (3) and others. Overall
dislocation rate was 2/89 (2 %); both in revision THA. Overall cup revision rate was 5/89 (6 %): 3
septic, 1 periprosthetic acetabular fracture, 1 ”intraprosthetic dissociation”. 67 patients were available
for the standardized questionnaire at a median follow-up of 43 months (range 25-78). 19 patients were
not available for two-year follow-up: 17 died and two were lost to follow-up. CONCLUSIONS: This
study supports the use of DMCS constructs in primary and revision hip arthroplasty for specific high-
risk patients. We continue to indicate DMCS in this patient group. We do caution against extending
indications for DMCS to lower risk patient groups due to unknown issues surrounding wear and component
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Abstract
Introduction Double mobility cup systems (DMCS) have
gained increasing acceptance, especially in patients at high
risk for dislocation. The aim of this investigation was to
analyze the frequency and indications of the DMCS use in
our praxis and to evaluate dislocation and cup revision
rates after a minimum follow-up of 2 years.
Materials and methods All patients implanted with a
DMCS from May 2008 to August 2011 were identified
from our institutional database of primary and revision
THA procedures. Patient demographics, including ASA
score, were recorded, along with details of the surgical
procedures, indications for DMCS use, and post-operative
clinical course and any complications. Radiographs were
analyzed for implant positioning and radiological signs of
loosening.
Results 1046 primary THA were implanted, of these 39
(4 %) primary DMCS. Indications were severe neuromus-
cular disease (SND) (14), hip abductor degeneration
(HAD) (9), cognitive dysfunction (CD) (8) and others. 345
revision THA were performed, of these 50 (14 %) revision
DMCS. Indications were recurrent dislocations (27), mul-
tiple prior hip surgeries (13), HAD (5), CD (3) and others.
Overall dislocation rate was 2/89 (2 %); both in revision
THA. Overall cup revision rate was 5/89 (6 %): 3 septic, 1
periprosthetic acetabular fracture, 1 ‘‘intraprosthetic dis-
sociation’’. 67 patients were available for the standardized
questionnaire at a median follow-up of 43 months (range
25–78). 19 patients were not available for two-year follow-
up: 17 died and two were lost to follow-up.
Conclusions This study supports the use of DMCS con-
structs in primary and revision hip arthroplasty for specific
high-risk patients. We continue to indicate DMCS in this
patient group. We do caution against extending indications
for DMCS to lower risk patient groups due to unknown
issues surrounding wear and component longevity.
Keywords Double cup mobility system  Dislocation 
Total hip arthroplasty  Primary  Revision  Complications
Introduction
Double mobility cup systems (DMCS) have gained
increasing acceptance, especially in patients at high risk for
dislocation. Dislocation rates for contemporary primary
total hip arthroplasty (THA) range from 0.5 to 4.8 % [1–4],
while dislocation rates in revision surgery range from 7.4 to
14.4 % [5–7]. Apart from factors related to surgical tech-
nique such as implant positioning and surgical approach
[1–3, 8–10], patient related factors have an important
influence on dislocation rates.
Potential high-risk patient characteristics are numerous,
and rates of dislocation are higher than the general popu-
lation. Cognitive or neuromuscular disorders carry a dis-
location rate of up to 13 % in the first 3 months in primary
THA [11]. Female gender has been associated with a dis-
location rate of 3.8 % and it was 2.5 % in men after
10 year follow-up [3]. Likewise, advanced age (dislocation
rate of 9.2 % after 1 year in patients 80 years and older
[12] ) and multiple prior hip surgeries (instability rate of
4.8 % in patients with prior hip surgery compared to 2.4 %
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[1, 3, 8, 10, 13–15] ) represent risk factors. Hip abductor
insufficiency, with reported OR of 2.67 after a minimum
follow- up of 90 days in revision THA [16] and distinctly
higher dislocation rates in patients without hip abductors
for revision THA for 28 mm heads (40 vs. 13 %) and
36 mm heads (33 vs. 0 %) [17], is a key risk factor. In
primary THA, Woo et al. and Alberton et al. described the
correlation of abductor mechanism and soft tissue ten-
sioning in preventing dislocations [3, 6]. Poor overall
health as risk factor was reported by Jolles et al.: the odds
ratio of 10 was observed for dislocation in primary THA in
patients with an ASA score 3 and 4 [5].
In an effort to reduce dislocation rates constrained cups
have been used in high-risk patients. However, these con-
structs are limited by long- term failure rates of up to
26–42.1 % [18, 19]. Failure modes, such as aseptic loos-
ening, dissociation of the liner/cup interface, implant
breakage and high polyethylene wear rates have all been
reported. [18] The double mobility cup system was intro-
duced in 1976 by Gilles Bousquet in an effort to increase
stability while reducing polyethylene wear. This system
consists of two different articulations: a large uncon-
strained bearing surface and a smaller constrained articu-
lation. This theoretically increases ROM and the jump
distance, both potentially reducing the risk of dislocation.
[20] (Fig. 1). Low dislocation rates using DMCS in pri-
mary and revision THA have been reported by several
independent groups [21–27]. Newer studies have dimin-
ished the former concern of excessive polyethylene wear in
DMCS [28]. Further studies have shown significantly
reduced polyethylene wear with the use of highly cross-
linked polyethylene [29].
The use of DMCS in our department began in 2008 for
primary and revision hip arthroplasty in patients at high
risk for dislocation. The aim of this investigation was to
test our hypothesis that dislocation rates in this high-risk
patient population using DMCS would be similar to the
dislocation rates of lower risk patient groups after both
primary and revision THA with single-mobility THA
designs. Furthermore, we sought to compare the dislocation
risks with DMCS with that of the range given in the lit-
erature for primary and revision THA [2, 6].
Materials and methods
All patients implanted with a DMCS from May 2008 to
August 2011 were identified from our institutional database
of primary and revision THA procedures. Patient demo-
graphics, including American Society of Anesthesiologists
(ASA) score, were recorded, along with details of the
surgical procedures, indications for DMCS use, and post-
operative clinical course and any complications.
A standardized questionnaire specifically asking about
hip dislocation, revision surgery and antibiotic therapy was
administered to all patients. Western Ontario and
McMaster (WOMAC) scores were collected at least 2 years
postoperatively for all patients receiving a DMCS. Com-
plication data for the comparative group of patients
receiving standard, single articulation THA implants with
28 mm bearings were obtained from retrospective
chart review only. The primary endpoint of interest of this
study was dislocation and/or cup revision for any reason.
Post-operative radiographs of the DMCS group were
evaluated for implant positioning according to the safe zone
as described by Lewinnek [9]. In an anteroposterior pelvis
view anteversion was calculated according to Widmer [30]
and inclination was measured in relation to the inter-tear-
drop line. On the latest available x-ray examination, radio-
logical signs of loosening according to the system of DeLee
et al. [31] were evaluated for the DMCS group.
In primary THA a direct anterior approach was used
unless a hip abductor tear with tendon retraction more than
4 cm and/or fatty infiltration of greater than 3, using the
modified Goutallier scoring system according to Zanetti
et al. [32–34], was seen on MRI. In those cases, a lateral
approach via tendon tear was used as described by Mioz-
zari et al. [35], reconstructing the tendon prior to skin
closure. A preoperative MRI was obtained in patients with
clinical trochanteric pain syndrome and hip abductor
weakness. In revision THA a direct anterior approach was
used if the index approach was anterior; otherwise a pos-
terior approach was used.Fig. 1 DMCS Medacta
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In all cases either a cemented Versacem or a non-ce-
mented Versafit cup (Medacta International, Castel San
Pietro, Switzerland) was used. If necessary an anti-pro-
trusio cage (Ganz reinforcement ring, Zimmer Inc.,
Warsaw, IN, USA) was used. Depending on intraoperative
findings Quadra stems (Medacta International, Castel San
Pietro, Switzerland) or Revitan stems (Zimmer Inc.,
Warsaw, IN, USA) were used.
In the primary THA group 36 Quadra and 3 Revitan
stems were implanted. In revision THA cases 10 Quadra
stems and 10 Revitan stems were implanted. In the
remaining 30 cases the stem was not revised. The respec-
tive bearing couple diameters are shown in Fig. 2. Signif-
icantly larger cups were used in the revision THA group
(p = 0.001). Indications for trochanteric osteotomy in
primary THA were deformity of the proximal femur
metaphysis (3), broken intramedullary hardware (1) and a
high-riding greater trochanter (1). Indications for anti-
protrusio cages in primary THA were bony acetabular
defect (3) and intraoperative perforation while reaming (1).
Severe hip abductor damage was defined as hip abductor
tear with tendon retraction more than 4 cm and/or fatty
infiltration of greater than 3 using the modified Goutallier
scoring system [32–34].
Statistical analysis was performed using SPSS Statistics
21 package (IBM, Armonk, NY, USA). Demographic









Fig. 2 Femoral head and inlay couple (diameters)
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were analyzed using Chi Square and Mann–Whitney
U tests as appropriate. The distribution of continuous
variables was assessed graphically. Normally distributed
data were presented as mean ± standard deviation (SD) or
mean and confidence intervals, and non-parametric data
with median and range. The significance level was set to
less than 0.05.
Results
Between May 2008 and August 2011 1046 primary and
345 revision THA were performed at our institution. Of
these 39 DMCS (37 patients) were implanted in primary
and 50 DMCS (49 patients) as part of a revision THA.
Indications for DMCS use are summarized in Tables 1
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disease (n = 1)
Parkinson’s disease 1
a Analogous system using MRI
Table 3 Patient demographics
Total DMCS (n = 89) Primary THA (n = 39) Revision THA (n = 50) p value
Gender (female/male) 44/45 22/17 22/28 n.s.a
Age in years (range) 66 (23–92) 64 (23–92) 73 (26–90) n.s.
Body mass index (range) 27.2 (13–64) 26.1 (16–64) 28.3 (13–42) n.s.
ASAb score C3 39 15 24 n.s.
Side (right/left) 47/42 23/16 24/26 n.s.
Surgical approach
Direct anterior 33 26 7 0.001
Posterior 33 0 33 0.001
Lateral 8 8 0 0.001
Trochanteric osteotomy 15 5 10 n.s.
DMCS cup fixation method
Uncemented 58 32 26 0.003
Cemented 12 3 9 n.s.
Cemented into anti-protrusio cage 19 4 15 0.025
a
n.s. not significant (p[ 0.5)
b
ASA American Society of Anesthesiologists
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and 2 for primary and revision procedures, respectively.
In 17 cases, revision THA was for a septic etiology.
Table 3 summarizes patient demographic variables, sur-
gical side, approach and implants for the DMCS cohort.
Significantly more posterior approaches (p = 0.001) and
anti-protrusio cages (p = 0.025) were used in the revision
group. In 8 primary cases, a lateral approach was used in
order to repair hip abductor tears as described by Miozarri
et al. [35].
Overall two dislocations occurred (2 of 89 casese 2 %
dislocation rate), both in revision THA. These two dislo-
cations were from traumatic causes after the revision pro-
cedures, and they occurred between 4 and 8 weeks after
surgery. The first case was in a 69-year-old patient with
Parkinson’s disease after multiple septic revisions which
resulted in loss of the greater trochanter. Cup anteversion
and inclination in the revision THA were 21 and 40,
respectively (Fig. 3). The arthroplasty remained stable after
open reduction. The second dislocation occurred in a 60-
year-old male with Trisomy 21. Cup anteversion and
inclination were 23 and 43, respectively (Fig. 4). The
arthroplasty remained stable after closed reduction. The
survival rate with dislocation as an endpoint was 97.7 %
(CI = 94.5–100 %) in 75 patients after 12 months and
97.7 % (CI = 94.5–100 %) in 64 patients after 24 months.
During the same time period, 1007 primary THAs were
implanted and 295 revision THAs were performed using
standard 28 mm bearing couples. Dislocation rates were
0.7 % (7 of 1007) in the primary THA group, and 4 % (13
of 295) in the revision THA group at a minimum follow-up
of 2 years.
In addition to the two dislocations; five cups were revised
all after revision THAs. Three of the revisions were due to
deep sepsis. One cup revision was due to a periprosthetic
acetabular fracture after a fall 4 months after DMCS
implantation, and another due to dissociation of the Ver-
sacem cup from the anti-protrusio cage 2 years after surgery
(Fig. 5). The survival rate with all kind of reintervention
(closed reduction included) as an endpoint was 95.3 %
(CI = 90.7–99.9 %) in 75 patients after 12 months and
91 % (CI = 87.7–94.3 %) in 64 patients after 24 months.
Seventeen patients died at a median of 10 months (range
1–24) after index surgery. Two patients were lost to follow-
up; they were last seen after 3 and 14 months after index
surgery, respectively. At last patient contact, none of the 19
patients had sustained a dislocation or revision. Sixty-seven
patients were available for the standardized questionnaire
at a median of 43 months (25–78) after index surgery.
Fig. 3 Dislocation case 1, 69 years old female, indication for DMCS:
Parkinson’s disease, reason for dislocation: fall
Fig. 4 Dislocation case 2, 60 years old male, indication for DMCS:
trisomy 21, reason for dislocation: fall
Fig. 5 Dissociation cup/anti-protrusio cage, 45 years old female,
indication for DMCS: recurrent instability, reason for dissociation:
unknown
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WOMAC scores improved from 49.92 points pre-opera-
tively to 20.16 points [p = 0.01] in primary THA, and
from 47.04 points pre-operatively to 34.56 points at latest
follow-up [p = 0.03] after revision THA.
No osteolysis or progressive radiolucency changes were
detected at last radiologic follow-up. Implant positioning
outside of the safe zone with respect to either inclination or
anteversion occurred in 10 of 89 procedures (11 %).
Discussion
The aim of this investigation was to analyze the frequency of
DMCSuse in our practice and to evaluate dislocation and cup
revision rates at a minimum follow-up of 2 years. Our
hypothesis was that dislocation rates in a high-risk patient
cohort managed with DMCS would not differ from the dis-
location rates seen in primary and revision THA patient
groups implantedwith conventional, single-mobility designs
and 28 mm bearing couples. We also sought to compare the
complication rates with those experienced in the literature
for primary and revision THA [2, 6], respectively.
DMCS cups were used in 4 % of our primary THA, with
no dislocations after a minimum follow-up of 2 years. This
rate is comparable to other reports of DMCS in primary
THA. Vielpeau et al. reported no dislocations after
5.2 years while Philippot et al. reported no dislocations
after 10 years of follow-up [21, 22]. Both studies were
performed in unselected patient groups. In contrast our
study included a specific high-risk patient collective;
indications for primary THA included neuromuscular dis-
ease, severe irreversible hip abductor degeneration, cog-
nitive dysfunction, C3 prior hip surgeries, physical
handicaps and morbid obesity.
The rate of dislocation with use of DMCS in high-risk
patients is also superior compared to the rate in our low-risk
patient collective treated with conventional prosthesis and
28 mm bearings (0.7 %), especially regarding that the dis-
location rate of the conventional prosthesis is most likely
under-reported since dislocations treated at other hospitals
are not included. We conclude that DMCS is an effective
implant in minimizing dislocation in high-risk patients.
DMCS cups were used in 14 % of our revision THA;
indications for DMCS were recurrent instability, C3 prior
hip surgeries, severe irreversible hip abductor degenera-
tion, cognitive dysfunction, specific physical handicaps and
neuromuscular disease. This resulted in a dislocation rate
of 4 %. In our series both dislocations occurred after a fall.
An uneventful course followed after closed and open
reduction, respectively. Our dislocation rates in revision
THA were 4 % after a minimum follow- up of 2 years; this
is inferior to the 1.7 % dislocation rate after 4 years follow-
up published by Leiber et al. [27]. However, this
comparison study included all patients while our study
focused on high-risk patients only and may explain, in part,
our higher dislocation rate. Other dislocation rates in the
literature range from 3.4 to 5.5 % [36, 37]. Both studies
were performed in all-comers with respect to hip arthro-
plasty procedures.
When compared to the revision rate using conventional
THA with 28 mm bearings (4 %), rates are comparable at
our institution and distinctly lower than dislocation rates
observed in the literature: i.e., 7.4 % rate in a study by
Alberton et al. [6], and 9 % rate in a report by Kavanagh
et al. [38]. We conclude that the use of DMCS in the
revision procedures associated with high dislocation risk
patients can avoid increased rates of dislocation.
It has been shown that larger femoral heads of a mini-
mum of 36 mm are associated with a lower dislocation rate
in primary and revision THA [6, 39]. Howie et al. ran-
domized 644 patients to receive either 28 mm or 36 mm
bearing in primary THA demonstrating a significantly
lower dislocation rate at 1 year for the large diameter group
(0.8 vs. 4.4 %), and a strong trend in patients undergoing
revision THA in favor of the large diameter group (4.9 vs.
12.2) [39]. Garbuz et al. randomized patients in a 32 mm
vs. 36 mm/40 mm group; the larger head group demon-
strated a significantly lower rate of instability (1.1 vs.
8.7 %) at a mean of 5 years after operation [40]. Compared
with the literature a comparably low dislocation rate can be
achieved using larger femoral heads in an all-comers
patient collective, but direct comparisons to the use of
DMCS in a high-risk patient collective needs further study.
With respect to complications, one (1 %) ‘‘intrapros-
thetic dissociation’’ occurred 2 years after index surgery in
the revision group. Such complications have been reported
by other groups [22, 41]. Philippot suggested that younger
patients and the formation of excessive scar tissue are
specific risk factors for this complication.
Limitations of our study are the short radiologic follow-
up and the high percentage of patients not available for a
follow-up 2 years after index surgery mainly due to the
known high mortality rate. Both of these study limitations
are related to the advanced age, as well as medical and
surgical morbidities associated with this high-risk patient
population and revision hip surgery. Our mortality rate is
comparable to the 1 year mortality rate reported in the 2013
Australian National Joint Replacement Registry annual
report ranging from 5–35 % [42].
Conclusion
In conclusion, this study supports the use of DMCS con-
structs in primary and revision hip arthroplasty for specific
high-risk patient populations. To our knowledge this is the
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first published review of DMCS in a well selected high-risk
patient collective and it demonstrates that DMCS can
reduce dislocation rate comparable to rates seen in con-
ventional hip articulations, although the patient population
and the indications are not directly comparable. We con-
tinue to indicate DMCS in our patients at high risk for
dislocation. We do caution against extending indications
for DMCS to lower risk patient groups, younger patient
populations without specific risk factors for dislocation,
and for those with high activity levels due to unknown
issues surrounding wear and component longevity.
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(2009) Use of dual mobility socket to manage total hip arthro-
plasty instability. Clin Orthop Relat Res 467:465–472
37. Saragaglia D, Ruatti S, Refaie R (2013) Relevance of press-fit
dual mobility cup to deal with recurrent dislocation of conven-
tional total hip arthroplasty: a 29-case series. Eur J Orthop Surg
Traumatol 23:431–436. doi:10.1007s00590-012-1002-3
38. Kavanagh BF, Ilstrup DM, Fitzgerald RH (1985) Revision Total
Hip Arthroplasty. JBJS 67(4):517–526
39. Howie DW, Holubowycz OT, Middleton R (2012) Large femoral
heads decrease the incidence of dislocation after total hip arthro-
plasty: a randomized controlled trial. JBJS Am 94:1095–1102
40. Garbuz DS, Masri BA, Duncan CP et al (2012) The Frank
Stinchfield Award: dislocation in revision THA: do large heads
(36 mm nad 40 mm) result in reduced dislocation rates in a
randomized clinical trial? CORR 470:351–356
41. Phillipot R, Camilleri JP, Boyer B, Adam P, Farizon F (2009) The
use of a dual-articulation acetabular cup system to prevent dis-
location after primary total hip arthroplasty: analysis of 384 cases
at a mean follow-up of 15 years. SICOT 33:927–932. doi:10.
1007//s00264-008-0589-9
42. National Australian joint and hip arthroplasty registry: annual
report 2013
1762 Arch Orthop Trauma Surg (2015) 135:1755–1762
123
